检索结果 - Hongming Yu

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    N6-Methyladenosine–Mediated Up-Regulation of FZD10 Regulates Liver Cancer Stem Cells’ Properties and Lenvatinib Resistance Through WNT/β-Catenin and Hippo Signaling Pathways

    N6-Methyladenosine–Mediated Up-Regulation of FZD10 Regulates Liver Cancer Stem Cells’ Properties and Lenvatinib Resistance Through WNT/β-Catenin and Hippo Signaling Pathways 由 Jinghan Wang, Hongming Yu, Wei Dong, Cheng Zhang, Mingtai Hu, Wencong Ma, Xiaoqing Jiang, Hengyu Li, Pinghua Yang, Daimin Xiang

    出版 2023
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Effect of Intramyocardial Grafting Collagen Scaffold With Mesenchymal Stromal Cells in Patients With Chronic Ischemic Heart Disease

    Effect of Intramyocardial Grafting Collagen Scaffold With Mesenchymal Stromal Cells in Patients With Chronic Ischemic Heart Disease 由 Xiaojun He, Qiang Wang, Yannan Zhao, He Zhang, Bin Wang, Jun Pan, Jie Li, Hongming Yu, Liudi Wang, Jianwu Dai, Dongjin Wang

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Loss of hepatic aldolase B activates Akt and promotes hepatocellular carcinogenesis by destabilizing the Aldob/Akt/PP2A protein complex

    Loss of hepatic aldolase B activates Akt and promotes hepatocellular carcinogenesis by destabilizing the Aldob/Akt/PP2A protein complex 由 Xuxiao He, Li Min, Hongming Yu, Guijun Liu, Ningning Wang, Chunzhao Yin, Qiaochu Tu, Goutham Narla, Yongzhen Tao, Shuqun Cheng, Huiyong Yin

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Early Experience of TACE Combined with Atezolizumab plus Bevacizumab for Patients with Intermediate-Stage Hepatocellular Carcinoma beyond Up-to-Seven Criteria: A Multicenter, Single-Arm Study

    Early Experience of TACE Combined with Atezolizumab plus Bevacizumab for Patients with Intermediate-Stage Hepatocellular Carcinoma beyond Up-to-Seven Criteria: A Multicenter, Singl... 由 Kang Wang, Hongfei Zhu, Hongming Yu, Yuqiang Cheng, Yan‐Jun Xiang, Zhangjun Cheng, Yang Li, Tao Li, Dongxu Wang, Zhenyu Zhu, Shuqun Cheng

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Efficacy and safety of <scp>TACE</scp> combined with lenvatinib and <scp>PD</scp>‐1 inhibitors for unresectable recurrent <scp>HCC</scp>: A multicenter, retrospective study

    Efficacy and safety of <scp>TACE</scp> combined with lenvatinib and <scp>PD</scp>‐1 inhibitors for unresectable recurrent <scp>HCC</scp>: A multicenter, retrospective study 由 Weijun Wang, Zong‐Han Liu, Kang Wang, Hongming Yu, Yuqiang Cheng, Yan‐Jun Xiang, Jin‐Kai Feng, Liping Zhou, Hongkun Zhou, Weiwei Pan, Wei‐Xing Guo, Jie Shi, Shuqun Cheng

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Intensity-modulated radiotherapy combined with systemic atezolizumab and bevacizumab in treatment of hepatocellular carcinoma with extrahepatic portal vein tumor thrombus: A preliminary multicenter single-arm prospective study

    Intensity-modulated radiotherapy combined with systemic atezolizumab and bevacizumab in treatment of hepatocellular carcinoma with extrahepatic portal vein tumor thrombus: A prelim... 由 Kang Wang, Yan‐Jun Xiang, Hongming Yu, Yuqiang Cheng, Zong‐Han Liu, Jing-Ya Zhong, Shuang Feng, Qian‐Zhi Ni, Hongfei Zhu, Weiwei Pan, Jingjing Li, Chao Liang, Hongkun Zhou, Yan Meng, Wan Yee Lau, Shuqun Cheng

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: